Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy (Q35848356)
Jump to navigation
Jump to search
scientific article published on 23 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy |
scientific article published on 23 June 2005 |
Statements
1 reference
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy (English)
1 reference
Angela Dispenzieri
1 reference
Martha Q Lacy
1 reference
Morie A Gertz
1 reference
Mark R Litzow
1 reference
Philip R Greipp
1 reference
Scott A Van Wier
1 reference
Greg J Ahmann
1 reference
Kimberly J Henderson
1 reference
Rafael Fonseca
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference